Home/Filings/4/0001384101-24-000166
4//SEC Filing

Chambers Rebecca 4

Accession 0001384101-24-000166

CIK 0001384101other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:35 PM ET

Size

5.1 KB

Accession

0001384101-24-000166

Insider Transaction Report

Form 4
Period: 2024-11-12
Chambers Rebecca
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-11-12$38.34/sh15,275$585,663124,501 total
Footnotes (2)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $38.04 to $38.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001823563

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:35 PM ET
Size
5.1 KB